Targeting Epidermal Growth Factor Receptor with Ficus virens Metabolites to Manage Cancer Progression: Molecular Docking and ADME Study

• Published in: Advances in human biology Vol. 14; no. 3; pp. 227 - 234
• Main Authors: Alqurashi, Yaser E, Jamal, Azfar
• Format: Journal Article
• Language: English
• Published: 01.07.2024
• ISSN: 2321-8568; 2348-4691
• DOI: 10.4103/aihb.aihb_38_24

Introduction: Targeting epidermal growth factor receptor (EGFR) has been used in the treatment of several cancer types where EGFR has a notable involvement in signalling pathways. Medicinal plants are the oldest and healthiest source of medication used in modern pharmacological therapy. Previous research indicates that the compounds found in Ficus virens stem bark have significant therapeutic properties against a range of illnesses, including cancer. Therefore, in this study, molecular docking research was conducted to determine the binding interactions and affinity of secondary metabolites predicted in F. virens methanolic extract with the target protein, EGFR. Materials and Methods: Three-dimensional (3D) conformers of the secondary metabolism products and adenosine triphosphate (ATP) were collected from PubChem on 5 January 2024. The 3D structure of EGFR and its inhibitor was retrieved from the Protein Data Bank (PDB) databank and ligands and proteins were converted to AutoDock-compatible format and then the energy minimisation was performed by the Open Babel in PyRx. Finally, using PyRx-Python 0.8, molecular docking was done, and using Discovery Studio, visualisation was done as well. The grid box dimensions were specified at 30 Å ×30 Å ×25 Å, and the physiochemical property evaluation was done by the SwissADME online server. Results: In this study, molecular docking assessed 14 compounds, including phytochemicals and ATP, for their binding with EGFR (PDB Id: 1XKK). Redocking of lapatinib validated the results. Natural chemicals showed binding energies from −4.0 to −7.8 Kcal/mol, with oleic acid and iso-caryophyllene demonstrating promising interactions, sourced from F. virens . Despite some limitations, these compounds exhibit potential for EGFR-targeted drug development, despite one Lipinski’s rule violation. Conclusions: EGFR inhibitory activities of iso-caryophyllene and oleic acid, which were identified in the F. virens methanol extract, were remarkable and higher than that of the substrate; their potential opens up exciting new possibilities for moving forward with cancer treatment. It is encouraged to further investigate the in vivo effectiveness of iso-caryophyllene, by means of animal models and cell lines.